Effect of lifestyle intervention on cardiometabolic risk factors: Results of the POWER-UP trial

International Journal of Obesity

Volumn 37, Issue , 2013, Pages S19-S24

  Vetter, M L ^a   Wadden, T A ^a,b   Chittams, J ^c   Diewald, L K ^a   Panigrahi, E ^a   Volger, S ^a   Sarwer, D B ^a   Moore, R H ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HAVERFORD COLLEGE   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^d NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Cardiometabolic risk factors; Insulin resistance; Lifestyle intervention; Lipids; Weight loss

Indexed keywords

BEHAVIOR THERAPY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, REDUCING; DIRECTIVE COUNSELING; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY; PENNSYLVANIA; PRIMARY HEALTH CARE; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS;

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COUNSELING; FEMALE; HEALTH CARE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 84882304221     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.92     Document Type: Article

References (21)

1. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397-415.
2. Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J Suppl 2005; 7: L21-L26.
3. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34: 1481-1486.
4. Knowler WC, Barrett-Con nor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
5. Appel LJ, Champagne CM, Harsha HW, Cooper LS, Obarzanek E, Elmer PJ et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289: 2083-2093.
6. Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008; 299: 1139-1148.
7. Tate DF, Jackvony EH, Wing RR. Effects of internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA 2003; 289: 1833-1836.
8. Tsai AG, Wadden TA, Rogers MA, Day SC, Moore RH, Islam BJ. A primary care intervention for weight loss: results of a randomized controlled study. Obesity 2010; 18: 1614-1618.
9. Ockene IS, Hebert JR, Ockene JK, Saperia GM, Stanek E, Nicolosi R et al. Effect of a physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidémie population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). Arch Intern Med 1999; 159: 725-731.
10. Martin PD, Dutton GR, Rhode PC, Horswell RL, Ryan DH, Brantley PJ. Weight loss maintenance following a primary care intervention for low-income minority women. Obesity 2008; 16: 2462-2467.
11. Ashley St JM, Jeor ST, Schräge JP, Perumean-Chaney SE, Gilbertson MC, McCall NL et al. Weight control in the physician's office. Arch Intern Med 2001; 161: 1599-1604.
12. Yeh HC, Clark JM, Emmons KE, Moore RH, Bennett GG, Warner ET et al. Independent but coordinated trials: insights from the Practice-based Opportunities for Weight Reduction Trials Collaborative Research Group. Clin Trials 2010; 7: 322-332.
13. Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011; 365: 1969-1979.
14. Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, Daumit G et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 2011; 365: 1959-1968.
15. Bennett GG, Warner ET, Glasgow RE, Askew S, Goldman J, Ritzwoller DP et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med 2012; 172: 565-574.
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 2002; 106: 3143-3421.
17. Borushek A. The CalorieKing Calorie, Fat and Carbohydrate Counter. 8th edn. Family Health: Conta Mesa, CA, USA, 2008.
18. National Heart, Lung, and Blood Institute. Aim for a Healthy Weight. National Institutes of Health: Bethesda, MD, USA, 2005, NIH publication no. 05-5213.
19. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005; 353: 2111-2120.
20. Vetter ML, Wadden TA, Vinnard C, Moore RH, Khan Z, Volger S et al. Gender differences in relationship between symptoms of depression and high-sensitivity CRP. Int J Obes 2013; 37: S38-S43.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.